Literature DB >> 11602741

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.

C Fromantin1, B Jamot, J Cohen, L Piroth, P Pothier, E Kohli.   

Abstract

We investigated the rotavirus-specific lymphocyte responses induced by intranasal immunization of adult BALB/c mice with rotavirus 2/6 virus-like particles (2/6-VLPs) of the bovine RF strain, by assessing the profile of cytokines produced after in vitro restimulation and serum and fecal antibody responses. The cytokines produced by splenic cells were first evaluated. Intranasal immunization with 50 microg of 2/6-VLPs induced a high serum antibody response, including immunoglobulin G1 (IgG1) and IgG2a, a weak fecal antibody response, and a mixed Th1/Th2-like profile of cytokines characterized by gamma interferon and interleukin 10 (IL-10) production and very low levels of IL-2, IL-4, and IL-5. Intranasal immunization with 10 microg of 2/6-VLPs coadministered with the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin (LT) considerably enhanced the Th1/Th2-like response; notably, significant levels of IL-2, IL-4, and IL-5 were observed. Since rotavirus is an enteric pathogen, we next investigated the production of IL-2 and IL-5, as being representative of Th1 and Th2 responses, by Peyer's patch and mesenteric lymph node cells from mice immunized intranasally with 2/6-VLPs and LT. The results were compared to those obtained from splenic and cervical lymph node cells. We found that both cytokines were produced by cells from each of these lymphoid tissues. These results confirm the Th1/Th2-like response observed at the systemic level and show, on the assumption that T cells are the primary cells producing the cytokines after in vitro restimulation, that rotavirus-specific T lymphocytes are present in the intestine after intranasal immunization with 2/6-VLPs and LT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602741      PMCID: PMC114681          DOI: 10.1128/JVI.75.22.11010-11016.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

Authors:  M Marinaro; H F Staats; T Hiroi; R J Jackson; M Coste; P N Boyaka; N Okahashi; M Yamamoto; H Kiyono; H Bluethmann; K Fujihashi; J R McGhee
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

2.  Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.

Authors:  M Marinaro; P N Boyaka; R J Jackson; F D Finkelman; H Kiyono; E Jirillo; J R McGhee
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

3.  Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques.

Authors:  J R McGhee; H Kiyono; M Kubota; S Kawabata; C J Miller; T Lehner; K Imaoka; K Fujihashi
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

4.  Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.

Authors:  S E Crawford; M K Estes; M Ciarlet; C Barone; C M O'Neal; J Cohen; M E Conner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Rotavirus vaccines.

Authors:  Maureen Lynch; Joseph S. Bresee; Jon R. Gentsch; Roger I. Glass
Journal:  Curr Opin Infect Dis       Date:  2000-10       Impact factor: 4.915

6.  Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles.

Authors:  M M McNeal; M N Rae; J A Bean; R L Ward
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Authors:  L Yuan; A Geyer; D C Hodgins; Z Fan; Y Qian; K O Chang; S E Crawford; V Parreño; L A Ward; M K Estes; M E Conner; L J Saif
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

Authors:  I Takahashi; M Marinaro; H Kiyono; R J Jackson; I Nakagawa; K Fujihashi; S Hamada; J D Clements; K L Bost; J R McGhee
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

9.  Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines.

Authors:  F M Fernandez; M E Conner; D C Hodgins; A V Parwani; P R Nielsen; S E Crawford; M K Estes; L J Saif
Journal:  Vaccine       Date:  1998-03       Impact factor: 3.641

10.  Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.

Authors:  J Xu-Amano; H Kiyono; R J Jackson; H F Staats; K Fujihashi; P D Burrows; C O Elson; S Pillai; J R McGhee
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  20 in total

1.  Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France.

Authors:  Béatrice Nicollier-Jamot; Valérie Pico; Pierre Pothier; Evelyne Kohli
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 2.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 3.  Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

4.  Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.

Authors:  Alexandra Daley; Roger Randall; Michael Darsley; Naheed Choudhry; Nicola Thomas; Ian R Sanderson; Nick M Croft; Paul Kelly
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

5.  Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells.

Authors:  Sheng Zhang; Rafael Cubas; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Immunol       Date:  2009-04-18       Impact factor: 4.407

6.  Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.

Authors:  Davide Agnello; Christine A Hervé; Amandine Lavaux; Magali Darniot; Patrice Guillon; Annie Charpilienne; Pierre Pothier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes.

Authors:  Rafael Cubas; Sheng Zhang; Sunkuk Kwon; Eva M Sevick-Muraca; Min Li; Changyi Chen; Qizhi Yao
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

8.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.

Authors:  Suvi Lappalainen; Kirsi Tamminen; Timo Vesikari; Vesna Blazevic
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

10.  A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.

Authors:  Robert B Mandell; Ramesh Koukuntla; Laura J K Mogler; Andrea K Carzoli; Alexander N Freiberg; Michael R Holbrook; Brian K Martin; William R Staplin; Nicholas N Vahanian; Charles J Link; Ramon Flick
Journal:  Virology       Date:  2009-11-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.